The Asia Pacific Non-steroidal Anti-inflammatory Drugs Market would witness market growth of 6.2 % CAGR during the forecast period (2022-2028).
The most often prescribed medications in the world are non-steroidal anti-inflammatory medicines (NSAIDs). They are used to treat pain, fever, and inflammatory symptoms. It is comprehended that the medications known as NSAIDs are also those who reversibly inhibit cyclooxygenase (COX), and by extension, the synthesis of prostaglandins, despite the fact that the term is not very precise and could refer to a wide range of other medications used to treat chronic rheumatic disorders. As prostaglandins are ubiquitous aracoids that have a wide range of effects on different body parts, blocking their synthesis may have an impact on numerous system organs, which explains the variety of NSAID indications and side effects.
There are various different chemical families of NSAIDs, but their pharmacokinetic profile, potency, as measured by the IC50 or IC80 for the two isoforms of COX, and the proportion of their affinity for the COX isoforms all are potentially major traits. The medications' final effects and tolerance profile will be impacted by this equilibrium. In a nutshell, suppression of the COX1 isoform affects ductus arteriosus closure, gastrointestinal toxicity, uterine contractions in late pregnancy, and platelet synthesis of thromboxane. Although COX2 inhibition is anti-inflammatory, it also has an impact on renal and epithelial function. Certain NSAIDs which are more specific or favour the COX2 isoform were dubbed "Coxibs" for marketing purposes.
They don't differ in any way from what are known as traditional or non-selective NSAIDs, some of which might be more selective of COX2 than some so-called "Coxibs," in terms of their effects. Less gastrotoxicity is the outcome of enhanced COX2 selectivity, but it may also mean poorer pain relief and greater cardiovascular risk. Potentiality must, of course, be used to balance this. The COX-2 favouring medication diclofenac that is no longer selective at the levels employed, is by far the most effective NSAID at inhibiting COX.
Turmeric, a member of the ginger family and a source of curcumin, is a spice. It is used to relieve digestive issues, promote wound healing, and decrease inflammation in both Chinese & Ayurvedic medicine. Three times a day, 400–600 mg of turmeric powder is the recommended dosage. There aren't many side effects, but they can irritate the stomach, and in rare cases, consuming a high dose could result in gastric ulcers. Caution is advised if patients are taking large doses of NSAIDs or anticoagulant drugs. A method employed in conventional Chinese medicine is acupuncture. Acupuncture works by stimulating certain places on the body with tiny needles in order to treat diseases like pain or other issues.
The China market dominated the Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,268.5 Million by 2028. The Japan market is estimated to grow a CAGR of 5.5% during (2022 - 2028). Additionally, The India market would experience a CAGR of 6.9% during (2022 - 2028).
Based on Route of Administration, the market is segmented into Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Route of Disease Indication, the market is segmented into Arthritis, Migraine, Ophthalmic Diseases and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Non-steroidal Anti-inflammatory Drugs Market is Projected to reach USD 25.5 Billion by 2028, at a CAGR of 5.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., GlaxoSmithKline PLC, Bayer AG, Teva Pharmaceuticals Industries Ltd., Eli Lilly And Company, Sanofi S.A., AstraZeneca PLC, Viatris, Inc., and Merck & Co., Inc.
Scope of the Study
Market Segments Covered in the Report:
By Route of Administration
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By Disease Indication
- Arthritis
- Migraine
- Ophthalmic Diseases
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Dr. Reddy’s Laboratories Ltd.
- Pfizer, Inc.
- GlaxoSmithKline PLC
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Eli Lilly And Company
- Sanofi S.A.
- AstraZeneca PLC
- Viatris, Inc.
- Merck & Co., Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
1.4.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
1.4.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
1.4.4 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market
Chapter 4. Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Topical Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
5.1 Asia Pacific Retail Pharmacy Market by Country
5.2 Asia Pacific Hospital Pharmacy Market by Country
5.3 Asia Pacific Online Pharmacy Market by Country
Chapter 6. Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
6.1 Asia Pacific Arthritis Market by Country
6.2 Asia Pacific Migraine Market by Country
6.3 Asia Pacific Ophthalmic Diseases Market by Country
6.4 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country
7.1 China Non-steroidal Anti-inflammatory Drugs Market
7.1.1 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.1.2 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.1.3 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.2 Japan Non-steroidal Anti-inflammatory Drugs Market
7.2.1 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.2.2 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.2.3 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.3 India Non-steroidal Anti-inflammatory Drugs Market
7.3.1 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.3.2 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.3.3 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.4 South Korea Non-steroidal Anti-inflammatory Drugs Market
7.4.1 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.4.2 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.4.3 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.5 Singapore Non-steroidal Anti-inflammatory Drugs Market
7.5.1 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.5.2 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.5.3 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.6 Malaysia Non-steroidal Anti-inflammatory Drugs Market
7.6.1 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.6.2 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.6.3 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.7 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
7.7.1 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.7.2 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.7.3 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trails:
8.3 GlaxoSmithKline PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trails:
8.4 Bayer AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trails:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trails:
8.7 Sanofi S.A.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 AstraZeneca PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.9 Viatris, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
TABLE 1 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Arthritis Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Arthritis Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Migraine Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Migraine Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
TABLE 31 China Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 32 China Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 33 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 38 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 39 Japan Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 40 Japan Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 41 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 46 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 47 India Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 48 India Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 49 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 54 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 55 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 56 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 57 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 62 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 63 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 64 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 65 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 66 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 67 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 70 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 71 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 72 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 73 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 78 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 87 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 88 Key Information – Pfizer, Inc.
TABLE 89 Key Information – GlaxoSmithKline PLC
TABLE 90 Key Information – Bayer AG
TABLE 91 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 92 Key Information – Eli Lilly And Company
TABLE 93 Key Information – Sanofi S.A.
TABLE 94 KEY INFORMATION – ASTRAZENECA PLC
TABLE 95 key information – Viatris, Inc.
TABLE 96 KEY INFORMATION - MERCK & CO., INC.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Dr. Reddy’s Laboratories Ltd.